Skip to main content
Journal cover image

Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.

Publication ,  Journal Article
Li, B; Wang, Y; Xu, Y; Liu, H; Bloomer, W; Zhu, D; Amos, CI; Fang, S; Lee, JE; Li, X; Han, J; Wei, Q
Published in: Int J Cancer
June 1, 2018

Cutaneous melanoma (CM) is considered as a steroid hormone-related malignancy. However, few studies have evaluated the roles of genetic variants encoding steroid hormone receptor genes and their related regulators (SHR-related genes) in CM-specific survival (CMSS). Here, we performed a pathway-based analysis to evaluate genetic variants of 191 SHR-related genes in 858 CMSS patients using a dataset from a genome-wide association study (GWAS) from The University of Texas MD Anderson Cancer Center (MDACC), and then validated the results in an additional dataset of 409 patients from the Harvard GWAS. Using multivariate Cox proportional hazards regression analysis, we identified three-independent SNPs (RORA rs782917 G > A, RORA rs17204952 C > T and DNMT1 rs7253062 G > A) as predictors of CMSS, with a variant-allele attributed hazards ratio (HR) and 95% confidence interval of 1.62 (1.25-2.09), 1.60 (1.20-2.13) and 1.52 (1.20-1.94), respectively. Combined analysis of risk genotypes of these three SNPs revealed a decreased CMSS in a dose-response manner as the number of risk genotypes increased (ptrend  < 0.001); however, no improvement in the prediction model was observed (area under the curve [AUC] = 79.6-80.8%, p = 0.656), when these risk genotypes were added to the model containing clinical variables. Our findings suggest that genetic variants of RORA and DNMT1 may be promising biomarkers for CMSS, but these results needed to be validated in future larger studies.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Int J Cancer

DOI

EISSN

1097-0215

Publication Date

June 1, 2018

Volume

142

Issue

11

Start / End Page

2303 / 2312

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • ROC Curve
  • Quantitative Trait Loci
  • Proportional Hazards Models
  • Polymorphism, Single Nucleotide
  • Oncology & Carcinogenesis
  • Nuclear Receptor Subfamily 1, Group F, Member 1
  • Neoplasm Staging
  • Middle Aged
  • Melanoma, Cutaneous Malignant
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Li, B., Wang, Y., Xu, Y., Liu, H., Bloomer, W., Zhu, D., … Wei, Q. (2018). Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer, 142(11), 2303–2312. https://doi.org/10.1002/ijc.31243
Li, Bo, Yanru Wang, Yinghui Xu, Hongliang Liu, Wendy Bloomer, Dakai Zhu, Christopher I. Amos, et al. “Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.Int J Cancer 142, no. 11 (June 1, 2018): 2303–12. https://doi.org/10.1002/ijc.31243.
Li B, Wang Y, Xu Y, Liu H, Bloomer W, Zhu D, et al. Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer. 2018 Jun 1;142(11):2303–12.
Li, Bo, et al. “Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.Int J Cancer, vol. 142, no. 11, June 2018, pp. 2303–12. Pubmed, doi:10.1002/ijc.31243.
Li B, Wang Y, Xu Y, Liu H, Bloomer W, Zhu D, Amos CI, Fang S, Lee JE, Li X, Han J, Wei Q. Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer. 2018 Jun 1;142(11):2303–2312.
Journal cover image

Published In

Int J Cancer

DOI

EISSN

1097-0215

Publication Date

June 1, 2018

Volume

142

Issue

11

Start / End Page

2303 / 2312

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • ROC Curve
  • Quantitative Trait Loci
  • Proportional Hazards Models
  • Polymorphism, Single Nucleotide
  • Oncology & Carcinogenesis
  • Nuclear Receptor Subfamily 1, Group F, Member 1
  • Neoplasm Staging
  • Middle Aged
  • Melanoma, Cutaneous Malignant